Search

everythinglearnresearchcommunity

for

Search:↓

Obese women with PCOS show a male-like pattern in certain fat tissue gene expressions.

Spironolactone improved blood vessel function and cholesterol levels in non-obese women with PCOS.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

A new method accurately measures nine specific hormones in human blood.

The document concludes that PCOS has a strong genetic component, but more research is needed to fully understand the specific genes involved.

Women with low SHBG levels and a high 3a-diol G to SHBG ratio are likely to experience female pattern baldness, possibly due to a slight excess of androgens affecting sensitive hair bulbs.

Women with nonclassic congenital adrenal hyperplasia experience more sexual dysfunction and distress.

Women with PCOS have more depression and stress due to high androgen levels, not obesity or insulin resistance.

No link between hair loss and blood groups or Rhesus factor.

Hormonal treatments can help with acne but are not the first choice due to side effects and the need for careful patient selection.

Adults with polycystic ovary syndrome are much more likely to have obstructive sleep apnea.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

High levels of male hormones in pregnant mice cause heart enlargement and poor heart function in their female babies.

Scalp hair thinning in women with PCOS is linked to metabolic issues like abnormal glucose tolerance, high LDL, and skipped meals.

Hormonal treatments, including birth control and antiandrogens, can effectively treat acne in women.

PCOS in lean women is a serious health condition with implications beyond fertility, affecting metabolism and increasing cardiovascular disease risk.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

About 2.2% of women with symptoms of high male hormones have a mild form of congenital adrenal hyperplasia, and measuring a specific hormone level can accurately diagnose it.

Higher levels of unbound testosterone are linked to increased insulin resistance, especially in women with polycystic ovary syndrome.

The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.

No cure for female pattern hair loss, but various effective treatments exist.

Multiple treatments work best for hair loss.

Finasteride and minoxidil work best together for hair loss.

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

Finasteride for hair loss may cause long-lasting side effects like impotence and low libido, but trials lack proper safety reporting.

Women with only irregular periods or excess hair have a better hormone profile than those with full PCOS, but both groups are similar, indicating a need for better PCOS diagnosis methods.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Androgen self-administration might be controlled by membrane receptors, not nuclear ones.

Hormonal therapy is a good option for women with severe acne, especially when there's a chance of hormone imbalance.

The study found that women with hyperandrogenic PCOS have higher levels of AKT1 and AKT2 proteins in their cells, which may lead to cell dysfunction.